clinical trial spotlight: determining efficacy of immunotherapy in stage iii lung cancer
Published 9 years ago • 104 plays • Length 4:20Download video MP4
Download video MP3
Similar videos
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
42:48
immunotherapy for lung cancer
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
2:13
clinical trial spotlight: identifying lung cancer patients who respond to ponatinib
-
1:46
immunotherapy for patients with resectable nsclc & driver mutation-targeted therapies in lung cancer
-
3:59
clinical trials 101: what is a clinical trial? - program: patient education ambassadors 2023-24
-
3:22
acquired resistance in lung cancer treatment - lcvl 2024
-
1:44
extended interval dosing for pembrolizumab - lung cancer onctalk 2022
-
4:19
clinical trial spotlight: alchemist for early-stage alk and egfr lung cancer patients
-
5:30:11
full event mainstage 2023 targeted therapies in lung cancer patient forum on-demand
-
6:43
what factors determine a successful clinical trial? - lung cancer onctalk 2022
-
3:49
small cell lung cancer clinical trial: is ecog 2511 right for you?
-
1:58
lung cancer video library mandarin - immunotherapy in stage iii nsclc, pacific trial and imfinzi
-
11:49
grace targeted therapies lung cancer 2021 - online communities, education & partnership in research
-
12:04
currently enrolling clinical trials of single agent immunotherapies for patients with lung cancer
-
6:00
immunotherapy for patients with driver mutation - lung cancer video library
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
1:54
future directions of lung cancer treatment: minimal residual disease - lcvl 2024